Design Therapeutics, Inc. (DSGN)
NASDAQ: DSGN · Real-Time Price · USD
3.455
-0.115 (-3.22%)
May 14, 2025, 10:02 AM - Market open
Design Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Cash & Equivalents | 13.67 | 22.56 | 21.2 | 26.5 | 298.57 | 2.38 | Upgrade
|
| Short-Term Investments | 216.01 | 222.91 | 260.6 | 303.89 | 85.5 | 33.71 | Upgrade
|
| Cash & Short-Term Investments | 229.67 | 245.48 | 281.8 | 330.39 | 384.06 | 36.09 | Upgrade
|
| Cash Growth | -15.15% | -12.89% | -14.71% | -13.98% | 964.15% | 46771.43% | Upgrade
|
| Other Receivables | 1.41 | 1.26 | 1.43 | 1.12 | 0.11 | 0.01 | Upgrade
|
| Receivables | 1.41 | 1.26 | 1.43 | 1.12 | 0.11 | 0.01 | Upgrade
|
| Prepaid Expenses | 2.57 | 1.3 | 1.35 | 3.62 | 1.26 | 0.06 | Upgrade
|
| Other Current Assets | - | - | - | - | - | 0.07 | Upgrade
|
| Total Current Assets | 233.64 | 248.04 | 284.58 | 335.12 | 385.44 | 36.23 | Upgrade
|
| Property, Plant & Equipment | 3.4 | 3.63 | 4.63 | 5.56 | 5.12 | 0.07 | Upgrade
|
| Long-Term Deferred Charges | - | - | - | - | - | 0.21 | Upgrade
|
| Other Long-Term Assets | 0.43 | 0.43 | 0.43 | 0.46 | - | - | Upgrade
|
| Total Assets | 237.48 | 252.09 | 289.64 | 341.14 | 390.56 | 36.52 | Upgrade
|
| Accounts Payable | 3.18 | 2.19 | 1.94 | 3.03 | 1.62 | 1.4 | Upgrade
|
| Accrued Expenses | 4.24 | 5.48 | 6.97 | 7.11 | 3.17 | 0.93 | Upgrade
|
| Current Portion of Leases | 0.82 | 0.8 | 0.72 | 0.64 | 0.49 | - | Upgrade
|
| Total Current Liabilities | 8.24 | 8.46 | 9.62 | 10.78 | 5.28 | 2.33 | Upgrade
|
| Long-Term Leases | 1.32 | 1.53 | 2.33 | 3.05 | 3.14 | - | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | - | 0.15 | Upgrade
|
| Total Liabilities | 9.56 | 10 | 11.96 | 13.83 | 8.43 | 2.48 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0 | Upgrade
|
| Additional Paid-In Capital | 472.39 | 468.83 | 455.25 | 441.42 | 429.82 | 0.45 | Upgrade
|
| Retained Earnings | -244.93 | -227.21 | -177.63 | -110.76 | -47.46 | -11.92 | Upgrade
|
| Comprehensive Income & Other | 0.45 | 0.48 | 0.06 | -3.36 | -0.24 | 0.16 | Upgrade
|
| Total Common Equity | 227.92 | 242.1 | 277.69 | 327.31 | 382.13 | -11.32 | Upgrade
|
| Shareholders' Equity | 227.92 | 242.1 | 277.69 | 327.31 | 382.13 | 34.04 | Upgrade
|
| Total Liabilities & Equity | 237.48 | 252.09 | 289.64 | 341.14 | 390.56 | 36.52 | Upgrade
|
| Total Debt | 2.14 | 2.33 | 3.05 | 3.69 | 3.63 | - | Upgrade
|
| Net Cash (Debt) | 227.53 | 243.14 | 278.75 | 326.7 | 380.43 | 36.09 | Upgrade
|
| Net Cash Growth | -15.04% | -12.77% | -14.68% | -14.12% | 954.09% | - | Upgrade
|
| Net Cash Per Share | 4.02 | 4.30 | 4.98 | 5.86 | 8.28 | 2.28 | Upgrade
|
| Filing Date Shares Outstanding | 56.77 | 56.76 | 56.49 | 55.9 | 55.46 | 15.96 | Upgrade
|
| Total Common Shares Outstanding | 56.77 | 56.75 | 56.47 | 55.9 | 55.44 | 15.96 | Upgrade
|
| Working Capital | 225.41 | 239.58 | 274.96 | 324.34 | 380.15 | 33.9 | Upgrade
|
| Book Value Per Share | 4.01 | 4.27 | 4.92 | 5.86 | 6.89 | -0.71 | Upgrade
|
| Tangible Book Value | 227.92 | 242.1 | 277.69 | 327.31 | 382.13 | -11.32 | Upgrade
|
| Tangible Book Value Per Share | 4.01 | 4.27 | 4.92 | 5.86 | 6.89 | -0.71 | Upgrade
|
| Machinery | 2.9 | 2.91 | 2.6 | 2.32 | 1.54 | 0.08 | Upgrade
|
| Construction In Progress | 0.13 | - | - | - | 0.01 | - | Upgrade
|
| Leasehold Improvements | 0.15 | 0.15 | 0.15 | 0.15 | 0.1 | - | Upgrade
|
Updated Mar 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.